Adaptive Immune Dysregulation in Disseminated Coccidioidomycosis

播散性球孢子菌病的适应性免疫失调

基本信息

  • 批准号:
    10554381
  • 负责人:
  • 金额:
    $ 19.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-01-24 至 2026-12-31
  • 项目状态:
    未结题

项目摘要

Abstract Disseminated coccidioidomycosis (DCM) can be explained by a combination of defective host defenses and successful immune evasion by the fungus. Published data from our labs highlight the importance of T cells in fighting fungal infections, and in going awry in disseminated disease. Our main goal is to discover the T cell patterns and programs that mediate dysfunction and allow for invasive coccidioidomycosis. T-cell activation requires the antigens of the pathogen to be presented, and this process offers an opportunity for adaptive immunity to founder. Major histocompatibility complex (MHC) subtypes, commonly also called HLA alleles, have been shown to play an important role in susceptibility to severe infection, including coccidioidomycosis, because these molecules present antigenic peptides to T cells. Which HLA alleles contribute to susceptibility has not been studied in over 20 years, and modern approaches including those published by our team shed considerably more light on the antigen presentation process. Importantly, which peptides are important for protection to coccidioidomycosis is as yet unknown. Our approach data includes a new technology to empirically discover those key peptides of Coccidioides. In Aim 1, we will discover the antigenic peptides, HLAs, and T-cell receptors that mediate DCM. Upon T-cell activation, transcriptional programs arise as cued by cytokines of the antigen presenting cells. Our published and preliminary data support that T-cell dysfunction underlies the defective immune responses of DCM. These aberrant responses may arise either due to genetic or epigenetic defects of the T cell program, which may be due to rare or common genetic variants or haplotype variants associated with genetic ancestry. These aberrant responses could also be due to abnormal skewing due to cytokines made by APCs. Clearance of pathogens within a few days is requisite, or else persistent antigen exposure drives T cells to a profound phenotypic switch that includes physical elimination of antigen-specific T cells, driving them to a state of antigen- unresponsiveness, or driving them to a state of senescence. Our preliminary data support that in subjects with DCM, T cells exhibit both an exhaustion and senescence phenotype. In Aim 2, we will first take an unbiased approach to discover transcriptional patterns that highlight DCM versus UVF. We will pursue single-cell RNA- seq and scATAC-seq to identify cells and patterns of transcription that correlate with disease. We will study subjects with DCM who bear the markers of the three dysfunctional programs above with this approach. These studies will enable discovery of the various subcategories of DCM patients and the functional deficiencies in their T cells.
抽象的 播散性球孢子菌病 (DCM) 可以通过宿主防御缺陷和 真菌成功逃避免疫。我们实验室发布的数据强调了 T 细胞在 对抗真菌感染,并避免传播疾病。我们的主要目标是发现 T 细胞 介导功能障碍并允许侵袭性球孢子菌病的模式和程序。 T 细胞激活需要呈递病原体抗原,这个过程提供了 创始人获得适应性免疫的机会。主要组织相容性复合体 (MHC) 亚型,通常也 被称为 HLA 等位基因,已被证明在严重感染的易感性中发挥重要作用,包括 球孢子菌病,因为这些分子向 T 细胞呈递抗原肽。哪些 HLA 等位基因有贡献 20 多年来一直没有对易感性进行研究,现代方法,包括由 我们的团队对抗原呈递过程有了更多的了解。重要的是,哪些肽是 对于预防球孢子菌病的重要性尚不清楚。我们的方法数据包含一项新技术 凭经验发现球孢子菌的那些关键肽。在目标1中,我们将发现抗原肽, HLA 和介导 DCM 的 T 细胞受体。 T 细胞激活后,在抗原呈递细胞的细胞因子的提示下出现转录程序。 我们发表的初步数据支持 T 细胞功能障碍是免疫反应缺陷的基础 DCM。这些异常反应可能是由于 T 细胞程序的遗传或表观遗传缺陷引起的, 这可能是由于罕见或常见的遗传变异或与遗传血统相关的单倍型变异造成的。 这些异常反应也可能是由于 APC 产生的细胞因子引起的异常偏差所致。清除 几天内消灭病原体是必要的,否则持续的抗原暴露会导致 T 细胞陷入严重的死亡状态。 表型转换,包括物理消除抗原特异性 T 细胞,驱使它们进入抗原状态 反应迟钝,或使他们进入衰老状态。我们的初步数据支持在受试者中 DCM 中,T 细胞同时表现出衰竭和衰老表型。在目标 2 中,我们将首先采取无偏见的 发现突出 DCM 与 UVF 的转录模式的方法。我们将追求单细胞RNA- seq 和 scATAC-seq 来识别与疾病相关的细胞和转录模式。我们将学习 使用这种方法,患有扩张型心肌病的受试者具有上述三种功能失调程序的标记。这些 研究将能够发现 DCM 患者的各个亚类及其功能缺陷 T细胞。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MANISH J BUTTE其他文献

MANISH J BUTTE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MANISH J BUTTE', 18)}}的其他基金

Immunoengineering cellobiose as a fuel source for T cells
免疫工程纤维二糖作为 T 细胞的燃料来源
  • 批准号:
    10661076
  • 财政年份:
    2022
  • 资助金额:
    $ 19.88万
  • 项目类别:
Host Immunogenetics and Fungal Virulence Mechanisms in Coccidioidomycosis
球孢子菌病的宿主免疫遗传学和真菌毒力机制
  • 批准号:
    10356724
  • 财政年份:
    2022
  • 资助金额:
    $ 19.88万
  • 项目类别:
Host Immunogenetics and Fungal Virulence Mechanisms in Coccidioidomycosis
球孢子菌病的宿主免疫遗传学和真菌毒力机制
  • 批准号:
    10554360
  • 财政年份:
    2022
  • 资助金额:
    $ 19.88万
  • 项目类别:
Adaptive Immune Dysregulation in Disseminated Coccidioidomycosis
播散性球孢子菌病的适应性免疫失调
  • 批准号:
    10356729
  • 财政年份:
    2022
  • 资助金额:
    $ 19.88万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10356725
  • 财政年份:
    2022
  • 资助金额:
    $ 19.88万
  • 项目类别:
Immunoengineering cellobiose as a fuel source for T cells
免疫工程纤维二糖作为 T 细胞的燃料来源
  • 批准号:
    10539922
  • 财政年份:
    2022
  • 资助金额:
    $ 19.88万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10554361
  • 财政年份:
    2022
  • 资助金额:
    $ 19.88万
  • 项目类别:
Collaborative multi-site project to speed the identification and management of rare genetic immune diseases
加速罕见遗传免疫疾病的识别和管理的多站点合作项目
  • 批准号:
    10549340
  • 财政年份:
    2021
  • 资助金额:
    $ 19.88万
  • 项目类别:
Collaborative multi-site project to speed the identification and management of rare genetic immune diseases
加速罕见遗传免疫疾病的识别和管理的多站点合作项目
  • 批准号:
    10359836
  • 财政年份:
    2021
  • 资助金额:
    $ 19.88万
  • 项目类别:
T-cell Dysfunction as the basis of Disseminated Coccidioidomycosis
T 细胞功能障碍是播散性球孢子菌病的基础
  • 批准号:
    10338193
  • 财政年份:
    2021
  • 资助金额:
    $ 19.88万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 19.88万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 19.88万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 19.88万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 19.88万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 19.88万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 19.88万
  • 项目类别:
    Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 19.88万
  • 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 19.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 19.88万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 19.88万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了